Results 81 to 90 of about 2,575,606 (330)

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Online Autonomous Motion Control of Communication-Relay UAV with Channel Prediction in Dynamic Urban Environments

open access: yesDrones
In order to improve the network performance of multi-unmanned ground vehicle (UGV) systems in urban environments, this article proposes a novel online autonomous motion-control method for the relay UAV.
Cancan Tao, Bowen Liu
doaj   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Orthogonal Functions Applied in Antenna Positioning

open access: yesAdvances in Electrical and Computer Engineering, 2010
In this paper, we present a method for designing orthogonal, Legendre type filters. Realization of these filters is very simple and they are very fast, robust and precise.
JOVANOVIC, Z.   +5 more
doaj   +1 more source

Convergence Rates of Inexact Proximal-Gradient Methods for Convex Optimization [PDF]

open access: yes, 2011
We consider the problem of optimizing the sum of a smooth convex function and a non-smooth convex function using proximal-gradient methods, where an error is present in the calculation of the gradient of the smooth term or in the proximity operator with ...
Bach, Francis   +2 more
core   +5 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Design of Diffractive Neural Networks for Solving Different Classification Problems at Different Wavelengths

open access: yesPhotonics
We consider the problem of designing a diffractive neural network (DNN) consisting of a set of sequentially placed phase diffractive optical elements (DOEs) and intended for the optical solution of several given classification problems at different ...
Georgy A. Motz   +6 more
doaj   +1 more source

Policy gradient methods

open access: yesScholarpedia, 2010
A policy gradient method is a reinforcement learning approach that directly optimizes a parametrized control policy by gradient descent. It belongs to the class of policy search techniques that maximize the expected return of a policy in a fixed policy class while traditional value function approximation approaches derive policies from a value function.
openaire   +2 more sources

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy